Insmed Netherlands B.V.
2 products tracked · names used in filings: Insmed Netherlands B.V.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Tue 18 Nov 2025🇪🇺 EU approval (EC decision)
Brinsupri (Brensocatib) approved in the EU
Marketing authorisation to Insmed Netherlands B.V.; PRIME, Additional monitoring · source
Thu 16 Oct 2025🇪🇺 CHMP positive opinion
Brinsupri (Brensocatib): CHMP positive opinion
Insmed Netherlands B.V.; PRIME, Additional monitoring · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Brinsupri Brensocatib | Authorised | 2025-11-18 |
| 🇪🇺 | Arikayce liposomal amikacin | Authorised | 2020-10-27 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.